AGC
AGN.PRA

Angelo Gordon & Co’s Allergan plc AGN.PRA Stock Holding History

Angelo Gordon & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-500
Closed -$423K – 92
2017
Q1 		$423K Sell
500
-11,625
-96% -$9.63M 0.03% 73
2016
Q4 		$9.23M Sell
12,125
-11,875
-49% -$8.97M 0.68% 40
2016
Q3 		$19.6M Buy
+24,000
New +$20.7M 1.48% 21
2016
Q2 		– Sell
-51,500
Closed -$47.3M – 64
2016
Q1 		$47.3M Buy
51,500
+5,000
+11% +$4.78M 3.4% 8
2015
Q4 		$47.8M Buy
46,500
+10,000
+27% +$10M 3.57% 6
2015
Q3 		$34.3M Buy
36,500
+5,000
+16% +$5.21M 2.49% 11
2015
Q2 		$32.8M Buy
+31,500
New +$33M 1.84% 17

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Angelo Gordon & Co's AGN.PRA Position: Q2 2017 in Review

Angelo Gordon & Co sold out of Allergan plc (AGN.PRA) in Q2 2017, closing a stake of 500 shares — an estimated $423K sold.

Angelo Gordon & Co first reported a position in AGN.PRA in Q2 2015 and held it in 7 quarters. The position peaked at $47.8M in Q4 2015. 109 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2017.

  • Angelo Gordon & Co reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Angelo Gordon & Co sold 500 Allergan plc shares in Q2 2017, an estimated $423K.
  • Angelo Gordon & Co first reported a position in Allergan plc in Q2 2015 and held it in 7 quarters.
  • Angelo Gordon & Co's Allergan plc position peaked at $47.8M in Q4 2015.
  • 109 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Angelo Gordon & Co's 13F filing for Q2 2017, filed 14 Aug 2017.